Skip to main content
SpringerLink
Log in

Pharmacokinetics of nicorandil in patients with normal and impaired renal function

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics of oral nicorandil 20 mg 12 hourly for 9 doses was evaluated in 21 hospitalized patients with angina pectoris due to coronary heart disease and with normal and impaired renal function. Patients were divided into 3 groups based on creatinine clearance (CLCr): GROUP I (n=6) > 80 ml/min, GROUP II (n=8) 20–80 ml/min, and GROUP III (n=7) < 20 ml/min.

After the first dose, the total clearance of nicorandil (CL) value did not change with increasing renal failure and so was not dependent on creatinine clearance. After the last dose CL was 51 l·h−1 in Group I, 44 l·h−1 in Group II and 56 l·h−1 in Group III, and it was not related to creatinine clearance. The percentage of the dose excreted in the urine was 0.4%. No significant difference was noted in any of the other pharmacokinetic parameters examined in the three groups, not even on comparing values obtained on the first and last days of treatment.

The findings suggest that there is no need to change the dose of nicorandil in subjects with different degrees of renal failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Uchida Y, Yoshimoto N, Murao S (1977) Effect of 2-nicotinamidoethyl nitrate (SG 75) on coronary circulation. Jpn Heart J 19: 112–124

    Google Scholar 

  2. Sakai K (1989) Nicorandil: animal pharmacology. Am J Cardiol 63: 2J-3J

    Google Scholar 

  3. Leonetti G, Fruscio M, Gradnik R, Chianca R, Bolla GB, Prandi P, Zanchetti A (1989) Nicorandil, a new vasodilator drug, in patients with essential hypertension. J Hypertens Bull 7: S292–293

    Google Scholar 

  4. Gali N, Varani E, Maiello L, Boriani G, Boschi S, Binetti G, Magnani B (1990) Usefulness of nicorandil in congestive heart failure. Am J Cardiol 65: 343–348

    Google Scholar 

  5. Katagiri T, Mochizuki M, Umetsu K, Hiroshige J, Geshi E, Konno N (1989) Protection of acute ischemic myocardial injury by pharmacological intervention. Jpn Circ J 53: 1108–1114

    Google Scholar 

  6. Inoue I, Nakaya Y, Nakaya S, Mori H (1989) Extracellular Ca2+-activated in coronary artery smooth muscle cells and its role in vasodilation. FEBS Lett 255: 281–284

    Google Scholar 

  7. Sakai K, Shiraki Y, Nabata H (1981) Cardiovascular effects of a new coronary vasodilator SG 75: comparison with nitroglycerine and diltiazem. J Cardiovasc Pharmacol 3: 139–150

    Google Scholar 

  8. Thormann J, Schlepper M, Kramer W, Gottwik M, Kindler M (1983) Effectiveness of Nicorandil (SG 75), a new long-acting drug with nitroglycerin effect, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina. J Cardiovasc Pharmacol 5: 371–377

    Google Scholar 

  9. Taira N, Satho K, Yanagisawa T, Imai Y, Hiwatari M (1979) Pharmacological profile of a new coronary vasodilator drug: 2-nicotinamidoethyl nitrate (SG 75). Clin Exp Pharmacol Physiol 6: 301–316

    Google Scholar 

  10. Mizukami M, Tamoike H, Inou T, Watanabe K, Kikuchi Y, Nakamura M (1981) Effect of 2-nicotinamidoethyl nitrate (SG 75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs. Drug Res 31: 1244–1247

    Google Scholar 

  11. Preuss KC, Gross GJ, Brooks HL, Waltier DC (1985) Hemodynamic action of nicorandil, a new antianginal agent with conscious dog. J Cardiovasc Pharmacol 7: 709–714

    Google Scholar 

  12. Suryapranata H, Serruys PW, De Feyter PJ, Werdouw PD, Hugenholts PG (1988) Coronary vasodilatory actions after a single dose of nicorandil. Am J Cardiol 61: 292–297

    Google Scholar 

  13. Hisa Y, Hamai K, Wada T, Aihara T, Bando M, Nakai Y, Kataoka Y (1989) Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris. Tokushima J Exp Med 36: 65–70

    Google Scholar 

  14. Tice FD, Binkley PF, Cody RJ, Moeschberger ML, Mohrland JS, Wolf DL, Leier CV (1990) Hemodynamic effects of oral nicorandil in congestive heart failure. Am J Cardiol 65: 1361–1367

    Google Scholar 

  15. Henry PJ, Horowitz JD, Louis WJ (1990) Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity. J Cardiovasc Pharmacol 15: 365–370

    Google Scholar 

  16. Kambara H, Nakamura Y, Tamaki S, Kawai C (1987) Beneficial effects of nicorandil on cardiovascular hemodynamics and left ventricular function. J Cardiovasc Pharmacol 10 [Suppl 8]: S104-S108

    Google Scholar 

  17. Sakai K, Ohba Y, Akima M, Kamiyama H, Hinohara Y, Nakano H (1980) Pharmacodynamic and metabolism studies on a new coronary vasodilator, N-(2-hydroxyethyl)nicotinamide nitrate (SG 75). Jpn J Pharmacol 30: 881–890

    Google Scholar 

  18. Belz GG, Matthews J, Heinrich J, Wagner G (1984) Controlled comparison of the pharmacodynamic effects of nicorandil (SG 75) and isosorbide dinitrate in man. Eur J Clin Pharmacol 26: 681–685

    Google Scholar 

  19. Nabata H, Shiraki Y, Sakai K (1981) Development of tolerance and a new coronary vasodilator, N(2-hydroxyethyl)nicotinamide nitrate (SG 75): a comparsion with nitroglycerin. Jpn J Pharmacol 31: 511–519

    Google Scholar 

  20. Kuronaru O, Sakai K (1986) Comparison of development of tolerance between nicorandil and nitroglycerine in anaesthetized open-chest dogs. Jpn J Pharmacol 42: 199–208

    Google Scholar 

  21. Sakai K, Kuronaro O (1987) Nitrate tolerance: comparison of nicorandil isosorbide dinitrate and nitroglycerine in anaesthetized dogs. J Cardiovasc Pharmacol 10 [Suppl 8]: S517-S524

    Google Scholar 

  22. Tadeka K, Nakagawa Y, Katano Y, Imai S (1977) Effects of coronary vasodilators on large and small coronary arteries of dogs. Jpn Heart J 18: 92–101

    Google Scholar 

  23. Silke B, Verma SP, Ali MS, Goldhammer E, Taylor SH (1989) Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induce angina pectoris. Am J Cardiol 63: 49J-55J

    Google Scholar 

  24. Kobayashi K, Hakuta T (1987) Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine and propanolol. J Cardiovasc Pharmacol 10 [Suppl 8]: S109-S115

    Google Scholar 

  25. Coltart DJ, Signy M (1989) Acute hemodynamic effects of single dose nicorandil in coronary artery disease. Am J Cardiol 63 (21): 34J-39J

    Google Scholar 

  26. Camm AJ, Maltz MB (1989) A controlled single dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Am J Cardiol 63: 61J-65J

    Google Scholar 

  27. Meany TB, Richardson P, Camm AJ, Coltar J, Griffith M, Maltz MB, Signy M (1989) Exercise capacity after single and twice daily doses of nicorandil in chronic stable angina pectoris. Am J Cardiol 63: J66-J70

    Google Scholar 

  28. Frydman AM, Chappele P, Diekmann H, Bruno R, Thebauld JJ, Bouthier J, Caplain H, Ungethuem W, Gaillard C, Le Liboux J, Renard A, Gaillot J (1989) Pharmacokinetics of nicorandil. Am J Cardiol 63: 25J-33J

    Google Scholar 

  29. Solal AC, Jaeger P, Bouthier J, Juliard JM, Dahan M, Gourgon R (1989) Hemodynamic action of nicorandil in chronic congestive heart failure. Am J Cardiol 63: 44J-48J

    Google Scholar 

  30. Ishisaki T, Chiba K, Sakanuma T, Sasaki T, Kamiyama H, Nakano H (1984) Pharmacokinetics of nicorandil, a new coronary vasodilator, in dogs. J Pharm Sci 73: 494–498

    Google Scholar 

  31. Taira N, Satoh K, Yanagisawa T, Imai Y, Hiwatari M (1979) Pharmacological profile of a new coronary vasodilator drug 2-nicotinamidoethyl nitrate (SG 75). Clin Exp Pharmacol Physiol 6: 301–316

    Google Scholar 

  32. Horii D, Ishibashi A, Iwamoto A, Yakuri R (1984) Study of the bioavailability of nicorandil before and after meals. Clin Pharmacol 15 (4): 489–495

    Google Scholar 

  33. Sakai K, Nakano H, Nagano H, Uchida Y (1983) Nicorandil. In: Scriabine A (ed) New drug annual: cardiovascular drug. Raven Press, New York

    Google Scholar 

  34. Benet LZ, Galeazzi RL (1979) Non-compartmental determination of the steady-state volume of distribution. J Pharm Sci 68: 1071

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, IRCCS-“Policlinico S. Matteo, Pavia, Italy

    M. Molinaro, M. B. Regazzi, R. Rondanelli & E. Sartirana

  2. Nephrology Department, Fondazione Clinica del Lavoro, Pavia, Italy

    G. Villa, A. Salvadeo & S. Segagni

  3. University of Pavia, Pavia, Italy

    R. Rondanelli

Authors
  1. M. Molinaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. B. Regazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Salvadeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Segagni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Rondanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Sartirana
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molinaro, M., Villa, G., Regazzi, M.B. et al. Pharmacokinetics of nicorandil in patients with normal and impaired renal function. Eur J Clin Pharmacol 42, 203–207 (1992). https://doi.org/10.1007/BF00278485

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00278485

Key words

Search

Navigation